Kevin David Brown has officially filed a Form 3 with the SEC, confirming his role as Chief Financial Officer and Treasurer of Dawson Private Markets Evergreen Fund. This filing is significant as it reflects a commitment to regulatory compliance and transparency in the private markets sector.
Dawson Private Markets Evergreen Fund operates within the private equity space, focusing on investments that may not be publicly traded. The filing, dated November 4, 2026, indicates Brown's responsibilities and formalizes his position within the organization.
Background
Brown Kevin David is associated with Dawson Private Markets Evergreen Fund, which is registered under the Central Index Key (CIK) 0002100319. The fund is based in New York and operates under the SEC Act of 1934. The recent filing is part of a series of disclosures aimed at maintaining transparency in the private equity industry.
What the Filing Says
The Form 3 filing states that Brown is an officer of the company, specifically holding the title of CFO and Treasurer. It notes, "The undersigned hereby makes, constitutes and appoints Pamela Chen, Tessa Davis and Clara Lang as the undersigned’s true and lawful attorney-in-fact." This indicates that Brown has authorized these individuals to act on his behalf regarding SEC filings.
Impact
This filing may affect various stakeholders including investors, regulatory bodies, and other financial entities within the private equity sector. By formalizing Brown's role, the fund aims to enhance its governance and compliance structure, which is increasingly important in today's financial landscape.
What's Next
The filing does not say what happens next. However, it sets a precedent for future disclosures and may lead to additional filings as the company continues to operate within the regulatory framework.
Read Next
Holmes John McClain III reports stock transaction for GATX
Kodiak Gas Services CEO McKee Sells Shares Under Trading Plan
Finn Michael J acquires additional shares in Sanfilippo
Advisors Preferred Trust Files New Summary Prospectus
Lord Abbett Bond Debenture Fund updates portfolio management team
Recursion Pharmaceuticals reports change in ownership









